Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies

22 Jul 2019

Abstract excerpt

Chimeric antigen receptor-T (CAR-T) cells are the product of several decades of work in different scientific disciplines that has culminated in the development and approval of therapies that are effective against certain relapsed or refractory hematologic malignancies. In addition, CAR-T cells are under investigation for the treatment of other hematologic malignancies and solid tumors, as well as autoimmune and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CAR-T cell therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31328862
DOI: 10.1111/cts.12666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell TherapiesPMID 31328862Read ↗

Chimeric Antigen Receptor T-Cell Therapy: What We Expect SoonSemantic proximity Read ↗

Chimeric Antigen Receptor (CAR) T Cells: A Detailed Review of Origins, Engineering, and Therapeutic ImpactSemantic proximity Read ↗

Chimeric Antigen Receptors: A Paradigm Shift in ImmunotherapySemantic proximity Read ↗

Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell MalignanciesSemantic proximity Read ↗

Next-Generation Chimeric Antigen Receptor T-cellsSemantic proximity Read ↗

Significant Advancements and Evolutions in Chimeric Antigen Receptor DesignSemantic proximity Read ↗

Chimeric Antigen Receptor‐T Cell TherapySemantic proximity Read ↗

Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospectsSemantic proximity Read ↗

CAR T Cell Therapy: A Versatile Living DrugSemantic proximity Read ↗

Chimeric antigen receptor-modified T cells strike backSemantic proximity Read ↗

Chimeric Antigen Receptor T-cell Therapy to Target Hematologic MalignanciesSemantic proximity Read ↗

Fully human CD19-specific chimeric antigen receptors for T-cell therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.